71921-210Level 3
Valganciclovir (Valganciclovir)
**Product type:** Human Prescription Drug
**Active ingredient:** VALGANCICLOVIR
**Strength:** 50 mg/mL
**Dosage form:** Powder, For Solution
**Route:** Oral
**Labeler:** Florida Pharmaceutical Products, LLC
**Marketing category:** ANDA (ANDA216317)
**Pharmacologic class:** Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]
GET
/api/v1/systems/ndc_fda/nodes/71921-210Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.